Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing
Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing
Inventiva成功獲得2140萬歐元，成功完成34800萬歐元融資的第一階段。
- Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024.
- Proceeds from the completed first tranche to be primarily used to advance Inventiva's Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH.
- Appointment of Mark Pruzanski as new Chairman of the Board of Directors and Srinivas Akkaraju as new member of the Board of Directors.
- Inventiva獲得2140萬歐元，完成了11600萬歐元融資的第一部分，這是2024年10月14日宣佈的最高34800萬歐元多階段股權融資的一部分。
- 完成的第一階段所得款項將主要用於推進Inventiva的III期NATiV3臨牀試驗，該試驗評估lanifibranor在MASH患者中的療效。
- 任命Mark Pruzanski爲新任董事會主席，Srinivas Akkaraju爲新任董事會成員。
資訊熱榜
更新時間